Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Radin

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 11, 2016
Acute ampakine treatment ameliorates age-related deficits in long-term potentiationDaniel P Radin, Sheng Zhong, Richard Purcell, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2025
Is there a continued need for behavioral pharmacology in the discovery and development of medicines?Jeffrey M Witkin, Jodi L Smith, Daniel P Radin
Clinical Pharmacology in Drug Development|September 20, 2024
Safety, Tolerability, and Pharmacokinetic Profile of the Low-Impact Ampakine CX1739 in Young Healthy VolunteersDaniel P Radin, Rok Cerne, Jeffrey M Witkin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2018
Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brainDaniel P Radin, Steven Johnson, Richard Purcell, et al.
Synapse (New York, N.Y.)|September 20, 2024
High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkinesDaniel P Radin, Sheng Zhong, Rok Cerne, et al.
Biochemical Pharmacology|June 16, 2018
Tarps differentially affect the pharmacology of ampakinesDaniel P Radin, Yong-Xin Li, Gary Rogers, et al.
Biochemical Pharmacology|January 14, 2018
Stargazin differentially modulates ampakine gating kinetics and pharmacologyDaniel P Radin, Yong-Xin Li, Gary Rogers, et al.
European Journal of Pharmacology|August 9, 2025
Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trialDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Journal of Psychiatric Research|April 17, 2025
Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophreniaDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Anticancer Research|June 1, 2018
Ampakines Attenuate Staurosporine-induced Cell Death in Primary Cortical Neurons: Implications in the 'Chemo-Brain' PhenomenonDaniel P Radin, Gary A Rogers, Kimberley E Hewitt, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 11, 2016
Acute ampakine treatment ameliorates age-related deficits in long-term potentiationDaniel P Radin, Sheng Zhong, Richard Purcell, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2025
Is there a continued need for behavioral pharmacology in the discovery and development of medicines?Jeffrey M Witkin, Jodi L Smith, Daniel P Radin
Clinical Pharmacology in Drug Development|September 20, 2024
Safety, Tolerability, and Pharmacokinetic Profile of the Low-Impact Ampakine CX1739 in Young Healthy VolunteersDaniel P Radin, Rok Cerne, Jeffrey M Witkin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2018
Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brainDaniel P Radin, Steven Johnson, Richard Purcell, et al.
Synapse (New York, N.Y.)|September 20, 2024
High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkinesDaniel P Radin, Sheng Zhong, Rok Cerne, et al.
Biochemical Pharmacology|June 16, 2018
Tarps differentially affect the pharmacology of ampakinesDaniel P Radin, Yong-Xin Li, Gary Rogers, et al.
Biochemical Pharmacology|January 14, 2018
Stargazin differentially modulates ampakine gating kinetics and pharmacologyDaniel P Radin, Yong-Xin Li, Gary Rogers, et al.
European Journal of Pharmacology|August 9, 2025
Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trialDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Journal of Psychiatric Research|April 17, 2025
Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophreniaDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Anticancer Research|June 1, 2018
Ampakines Attenuate Staurosporine-induced Cell Death in Primary Cortical Neurons: Implications in the 'Chemo-Brain' PhenomenonDaniel P Radin, Gary A Rogers, Kimberley E Hewitt, et al.
Pageof 3